Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Morphic Holding Inc (NQ: MORF )

56.99 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Morphic Holding Inc

< Previous 1 2 3 4 5 Next >
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Will MORPHIC HOLDING INC Break Out? A Technical Analysis Perspective.
Investors are keeping a close eye on MORPHIC HOLDING INC (NASDAQ:MORF) as it boasts an impressive technical rating of 9 out of 10, signaling a possible breakout. 
Via Chartmill
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFC, HMNF, MORF on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, COFS, PFC, WSBC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
MORF Stock Earnings: Morphic Holding Misses EPS for Q2 2024
MORF stock results show that Morphic Holding missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGR, MORF, DRQ, SHCR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, HUDA, ALE, DOMA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHCR, MORF on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF
From Kahn Swick & Foti, LLC
Via Business Wire
Americans Are Flying; Airline Stocks Are Not
How the airline industry's focus on capacity and being able to supply more flights means fares are low, even in the face of record demand. 
Via The Motley Fool
3 Stocks for Patient Investors Looking to Build Generational Wealth
Investing in generational wealth stocks means holding them for years, preferably decades, to allow them to deliver supercharged returns. 
Via InvestorPlace
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-than-expected June inflation data and potential interest rate cuts. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
Megacaps and chip plays tumbled Thursday, but mostly still have healthy charts. 
Via Investor's Business Daily
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, MORF on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, INFN, AMBC, BEST on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF
From Kahn Swick & Foti, LLC
Via Business Wire
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Eli Lilly's acquisition of Morphic highlights strategic expansion in Immunology, targeting α4β7 for ulcerative colitis and Crohn's disease treatments. Goldman Sachs notes the deal's potential to... 
Via Benzinga
Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion – InsideArbitrage
Via AB Newswire
Hot Stocks: 3 Sleeping Giants About to Dominate Their Sectors
Give some consideration to these names, each of which has a strong competitive advantage and catalysts driving their share price higher. 
Via InvestorPlace
S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone
The CNN Money Fear and Greed index slightly decreased, remaining in Neutral zone. US stocks mixed, with S&P 500 at record high. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's Ozempic
Patients lost more more weight on Mounjaro than Ozempic. 
Via Investor's Business Daily
Gold Falls Over 1%; HilleVax Shares Plunge
Via Benzinga
Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What's Driving Markets Monday?
U.S. stocks started the week on a neutral note, with the S&P 500 and Nasdaq 100 indices hovering around the flatline by midday trading in New York. This comes after both indices reached fresh record... 
Via Benzinga
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Dow Turns Lower; Myomo Shares Jump
Via Benzinga
Topics Stocks
Exposures US Equities
Microsoft Layoffs 2024: What to Know as MSFT Enacts More Job Cuts
Microsoft layoffs hit the tech giant's employees last week as it reduced an unknown number of roles in two of its divisions. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, MORF, AGR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
NVDA Stock Warning: EU Watchdogs Are Sizing Up Nvidia
Nvidia stock is up on Monday even as investors in NVDA learn of warnings from EU regulators over its AI chip supply bottleneck. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Is Morphic (MORF) Stock Up 75% Today?
Morphic stock is up on Monday after the company signed a deal with Eli Lilly for the acquisition of MORF shares at $57 each in cash. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.